Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have been given a consensus rating of “Hold” by the fifteen brokerages that are currently covering the stock, Marketbeat reports. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $14.4231.
Several equities analysts have commented on AVTR shares. Robert W. Baird boosted their price target on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Evercore ISI decreased their target price on Avantor from $16.00 to $14.00 and set an “outperform” rating for the company in a report on Thursday, October 30th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $12.00 target price (down from $14.00) on shares of Avantor in a research note on Thursday, October 30th. Raymond James Financial lowered Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. Finally, Barclays reissued an “equal weight” rating and set a $12.00 price objective (down from $15.00) on shares of Avantor in a research report on Thursday, October 30th.
Read Our Latest Stock Analysis on Avantor
Insider Activity at Avantor
Institutional Trading of Avantor
Institutional investors have recently bought and sold shares of the business. Rise Advisors LLC purchased a new position in shares of Avantor in the 1st quarter valued at about $25,000. Northwestern Mutual Wealth Management Co. lifted its stake in Avantor by 288.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock worth $28,000 after purchasing an additional 1,263 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new position in Avantor in the second quarter valued at approximately $32,000. Finally, FNY Investment Advisers LLC acquired a new stake in Avantor during the second quarter worth approximately $36,000. 95.08% of the stock is owned by hedge funds and other institutional investors.
Avantor Stock Up 8.6%
Shares of NYSE:AVTR opened at $11.55 on Thursday. The firm has a market capitalization of $7.87 billion, a PE ratio of -88.81, a price-to-earnings-growth ratio of 3.66 and a beta of 0.93. Avantor has a 1 year low of $10.62 and a 1 year high of $23.32. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.49 and a quick ratio of 0.96. The firm’s 50-day moving average is $12.56 and its two-hundred day moving average is $12.87.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the previous year, the business posted $0.26 EPS. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Analysts predict that Avantor will post 1.06 EPS for the current year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- Insider Trading – What You Need to Know
- Market Momentum: 3 Stocks Poised for Major Breakouts
- The Significance of Brokerage Rankings in Stock Selection
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- How to Most Effectively Use the MarketBeat Earnings Screener
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
